Disabilities affecting intellectual abilities

Memory Health Receives Third Patent For Role In The Prevention And/Or Treatment Of Neurodegenerative Disease

Retrieved on: 
Tuesday, July 27, 2021
Branches of biology, Cognitive disorders, Psychiatry, Neuroscience, Learning disabilities, Psychiatric diagnosis, Dementia, Alzheimer's disease, Neurodegeneration, Mild cognitive impairment, Disabilities affecting intellectual abilities, Neuroscience of aging

The Intellectual Property Office of Ireland granted Memory Health the patent bearing the specification number 87241, on June 15, 2021.

Key Points: 
  • The Intellectual Property Office of Ireland granted Memory Health the patent bearing the specification number 87241, on June 15, 2021.
  • Memory Health is the only supplement patented specifically for the prevention and/or treatment of neurodegenerative disease.
  • The term Neurodegenerative disease describes a range of conditions such as memory loss, mild cognitive impairment, dementia, and Alzheimer's disease, primarily affecting the neurons in the human brain.
  • Memory Health is the gold standard of brain supplementation, the only patented formula for the prevention and/or treatment of neurodegenerative disease, especially dementia, in human subjects.